+ All Categories
Home > Documents > 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or...

2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or...

Date post: 02-Jun-2020
Category:
Upload: others
View: 5 times
Download: 0 times
Share this document with a friend
29
Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD - 1 - PUBLICATIONS INTERNATIONALES MAJ 15-01-2020 REVUES A COMITE DE LECTURE - 2020 - - 2019 - 1. ARBEZ B., KÜN-DARBOIS J.D., CONVERT T., GUILLAUME B., MERCIER P., HUBERT L., CHAPPARD D. Biomaterial granules used for filling bone defects constitute 3D scaffolds: porosity, microarchitecture and molecular composition analyzed by microCT and Raman microspectroscopy. J. Biomed. Mater. Res. Part B: Appl. Biomater. 107B, 415423, 2019. 2. ARBEZ B., MANERO F., MABILLEAU G., LIBOUBAN H., CHAPPARD D. Human macrophages and osteoclasts resorb β-tricalcium phosphate in vitro but not mouse macrophages. Micron online DOI :10.1016/j.micron.2019.102730 3. BORVON A. New data about the consumption of fish from the Alsace Region, France. Int J Osteoarchaeol. 29,407419, 2019. 4. CARDINAL M., TYS J., ROELS T., LAFONT S., OMINSKY MANUSCRIPT., DEVOGELAER J.P., CHAPPARD D., MABILLEAU G., AMMANN P., NYSSEN-BEHETS C., MANICOURT D.H. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta. Bone. 124, 137-147, 2019. 5. CARDINAL M., DESSAIN A.., ROELS T., LAFONT S., OMINSKY M.S., DEVOGELAER J.P., CHAPPARD D., MABILLEAU G., AMMANN P., NYSSEN-BEHETS C., MANICOURT D.H. Sclerostin-antibody treatment decreases fracture rates in axial skeleton and improves the skeletal phenotype in growing oim/oim mice Calcif. Tissue Int accepté pour publication 2019. 6. CHAPPARD D., KÜN-DARBOIS J.D., PASCARETTI-GRIZON F., CAMPRASSE G., CAMPRASSE S. Giant cells and osteoclasts present in bone grafted with nacre differ by nuclear cytometry evaluated by texture analysis. J Mater Sci Mater Med. 30, 2019. En ligne DOI: 10.1007/s10856-019-6293-z 7. COUPRY A, RONY L, DUCELLIER F., HUBERT L., CHAPPARD D. Texture analysis of trabecular bone around RM-Pressfit® cementless acetabulum in a series of 46 patients during a 5 year period. Orthop. Traumatol. Surg. Res., 105, 1283-1287, 2019. 8. DEGERATU C., MABILLEAU G., AGUADO E., MALLET R., CHAPPARD D., CINCU C., STANCU I.C. In vitro and in vivo behavior of polyhydroxyalkanoate (PHBV) fibers obtained by a wet spinning method. Morphologie, 103, 94-102, 2019. 9. KAHN A., KÜN-DARBOIS J.D., BERTIN H., CORRE P., CHAPPARD D. Mandibular bone effects of botulinum toxin injections in masticatory muscles in adult human. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. En ligne doi : 10.1016/j.oooo.2019.03.007, 2019.
Transcript
Page 1: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 1 -

PUBLICATIONS INTERNATIONALES MAJ 15-01-2020

REVUES A COMITE DE LECTURE

- 2020 -

- 2019 -

1. ARBEZ B., KÜN-DARBOIS J.D., CONVERT T., GUILLAUME B., MERCIER P., HUBERT L.,

CHAPPARD D. Biomaterial granules used for filling bone defects constitute 3D scaffolds: porosity, microarchitecture and molecular composition analyzed by microCT and Raman microspectroscopy. J. Biomed. Mater. Res. Part B: Appl. Biomater. 107B, 415–423, 2019.

2. ARBEZ B., MANERO F., MABILLEAU G., LIBOUBAN H., CHAPPARD D. Human macrophages

and osteoclasts resorb β-tricalcium phosphate in vitro but not mouse macrophages. Micron online DOI :10.1016/j.micron.2019.102730

3. BORVON A. New data about the consumption of fish from the Alsace Region, France. Int J

Osteoarchaeol. 29,407–419, 2019.

4. CARDINAL M., TYS J., ROELS T., LAFONT S., OMINSKY MANUSCRIPT., DEVOGELAER J.P., CHAPPARD D., MABILLEAU G., AMMANN P., NYSSEN-BEHETS C., MANICOURT D.H. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta. Bone. 124, 137-147, 2019.

5. CARDINAL M., DESSAIN A.., ROELS T., LAFONT S., OMINSKY M.S., DEVOGELAER J.P.,

CHAPPARD D., MABILLEAU G., AMMANN P., NYSSEN-BEHETS C., MANICOURT D.H.

Sclerostin-antibody treatment decreases fracture rates in axial skeleton and improves the skeletal

phenotype in growing oim/oim mice Calcif. Tissue Int accepté pour publication 2019.

6. CHAPPARD D., KÜN-DARBOIS J.D., PASCARETTI-GRIZON F., CAMPRASSE G., CAMPRASSE S. Giant cells and osteoclasts present in bone grafted with nacre differ by nuclear cytometry evaluated by texture analysis. J Mater Sci Mater Med. 30, 2019. En ligne DOI: 10.1007/s10856-019-6293-z

7. COUPRY A, RONY L, DUCELLIER F., HUBERT L., CHAPPARD D. Texture analysis of

trabecular bone around RM-Pressfit® cementless acetabulum in a series of 46 patients during a 5 year period. Orthop. Traumatol. Surg. Res., 105, 1283-1287, 2019.

8. DEGERATU C., MABILLEAU G., AGUADO E., MALLET R., CHAPPARD D., CINCU C.,

STANCU I.C. In vitro and in vivo behavior of polyhydroxyalkanoate (PHBV) fibers obtained by a wet spinning method. Morphologie, 103, 94-102, 2019.

9. KAHN A., KÜN-DARBOIS J.D., BERTIN H., CORRE P., CHAPPARD D. Mandibular bone effects

of botulinum toxin injections in masticatory muscles in adult human. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. En ligne doi : 10.1016/j.oooo.2019.03.007, 2019.

Page 2: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 2 -

10. KÜN-DARBOIS J.D., CHAPPARD D. Letter to the editor. The effects of Botulinum injection on bone

and cartilage of the mandibular condyle. Am. J. Orthodont. Dentofac. Orthop. Accepté pour publication :

2019

11. LOIN J., KÜN-DARBOIS J.D., GUILLAUME B., BADJA S., LIBOUBAN H., CHAPPARD D.

Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: same inflammatory response. J Mater Sci Mater Med. online DOI : 0.1007/s10856-019-6299-6 2019.

12. MANSUR S.A., MIECZKOWSKA A., FLATT P.R., CHAPPARD D., NIGEL IRWIN N.,

MABILLEAU G. Sitagliptin alters bone composition in high fat fed mice. Calcif. Tissue Int. on line 2019. doi: 0.1007/s00223-018-0507-0

13. MANSUR SA, MIECZKOWSKA A, FLATT PR, CHAPPARD D., IRWIN N, MABILLEAU G. The

GLP-1 Receptor agonist exenatide ameliorates bone composition and tissue material properties in high fat fed diabetic mice. Front Endocrinol (Lausanne). 2019 doi: 10.3389/fendo.2019.00051.

14. RONY L, PERROT R., HUBERT L., CHAPPARD D. Osteocyte staining with rhodamine in

osteonecrosis and osteoarthritis of the femoral head. Microsc. Res. Techn. 82, 2072-2078, 2019.

15. RONY L, AGUADO E., PASCARETTI-GRIZON F., HUBERT L., CHAPPARD D. Hyaluronic acid stimulates osseointegration of β-TCP in young and old ewes. Calcif. Tissue Int 105:487–496, 2019.

16. STANCU I. C., CHAPPARD D. Developments in hydrogel-based scaffolds and bioceramics for

bone regeneration. Book chapter. In “Bioceramics and biocomposites: from research to use in clinical practice”, I. Antoniac Ed, Wiley-Am. Ceram. Soc, 2017. ISBN-10: 1119049342. Livre disponible on line : https://www.amazon.com/Bioceramics-Biocomposites-Research-Clinical-Practice/dp/1119049342

- 2018 -

1. BALDINI N, PARE A, BADJA S, VEYSSIERE A, KÜN-DARBOIS J.D. Cholesterol granuloma of

the maxilla. Morphologie 102, 41-43, 2018. 2. BORVON A., GUINTARD C, MONCHOT H. A case of bone fracture with callus on the right

femur of a chicken (Gallus gallus domesticus, L. 1758) from the ancient site of Dharih, Jordan. Int. J. Paleopathol. 22, 135–139, 2018.

3. BORVON A, ANNE BRIDAULT A., BITON R, RABINOVICH R, PREVOST M, KHALAILYE M,

VALLA F.R. Finding of trout (Salmo cf. trutta) in the Northern Jordan Valley (Israel) at the end of the Pleistocene: Preliminary results. J. Archeologic. Sci. 18, 59–64, 2018.

Page 3: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 3 -

4. CHAPPARD D., MABILLEAU G., MASSON C., TALHA A., LEGRAND E. Metaplastic woven bone in bone metastases: a Fourier-transform infrared analysis and imaging of bone quality (FTIR). Morphologie. 102, 69-77, 2018.

5. CHAPPARD D, KÜN-DARBOIS J.D., MERCIER P., GUILLAUME B., AGUADO E.

Microcomputed tomography (microCT) and histology of the mandibular canal in human and laboratory animals. Morphologie 102, 263-275, 2018.

6. ESQUERRE N., BASSO L., DUBUQUOY C., DJOUINA M, CHAPPARD D., BLANPIED C,

DESREUMAUX P., VERGNOLLE N., VIGNAL C., BODY-MALAPEL M. Aluminum ingestion promotes colorectal hypersensitivity in rodents. Cell. Mol. Gastroenterol. Hepatol. 7, 185-196, 2018.

7. GOUSSAULT C, ALBERT JD, COIFFIER G, LAMER F, GUILLIN R, LE GOFF B, BOUVARD

B, DERNIS E, FERREYRA M, CORMIER G, GUGGENBUHL P, PERDRIGER A. Ultrasound characterization of ankle involvement in Löfgren syndrome. Joint Bone Spine. 85, 65-69, 2018.

8. KÜN-DARBOIS J.D., LIBOUBAN H., MABILLEAU G., PASCARETTI-GRIZON F., CHAPPARD

D. Bone mineralization and vascularization in bisphosphonate related osteonecrosis of the jaw: an experimental study in the rat. Clin Oral Invest. 22, 2997-3006, 2018.

9. LIBOUBAN H., GUINTARD C., MINIER N., AGUADO E., CHAPPARD D. Long term quantitative

evaluation of muscle and bone wasting induced by botulinum toxin in mice using microcomputed tomography. Calcif. Tissue Int. 102, 695-704, 2018

10. MABILLEAU G., GOBRON B., BOUVARD B, CHAPPARD D. Incretin-based therapy for the

treatment of bone fragility in diabetes mellitus. Peptides 100, 108-113, 2018. 11. MABILLEAU G., GOBRON B., MIECZKOWSKA A., PERROT R., CHAPPARD D. Efficacy of

targeting bone-specific GIP receptor in ovariectomy-induced bone loss. J. Endocrinol. On line doi: 10.1530/JOE-18-0214.

12. RONY L., de SAINTE HERMINE P, STEIGER V., MALLET R., HUBERT L., CHAPPARD D.

Characterization of wear debris released from alumina-on-alumina hip prostheses: analysis of retrieved femoral heads and peri-prosthetic tissues. Micron, 104, 89-94, 2018.

13. RONY L., LANCIGU R, HUBERT L. Intraosseous metal implants in orthopedics: a review.

Micron, 104, 89-94, 2018.

- 2017 -

1. AGUADO E., MABILLEAU G, GOYENVALLE E., CHAPPARD D. Hypodynamia alters bone quality and trabecular microarchitecture Calcif. Tissue Int. 100, 332-340, 2017.

2. CRUEL M, GRANKE M, BOSSER C, AUDRAN M, HOC T. Chronic alcohol abuse in men alters bone mechanical properties by affecting both tissue mechanical properties and microarchitectural parameters. Morphologie. 101, 88-96, 2017.

Page 4: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 4 -

3. DEGUETTE C., RAMOND-ROQUIN A., ROUGÉ-MAILLART C. Relationships between

age and microarchitectural descriptors of iliac trabecular bone determined by microCT Morphologie 101,64-70, 2017.

4. CRUEL M, GRANKE M, BOSSER C, AUDRAN M, HOC T. Chronic alcohol abuse in men alters bone mechanical properties by affecting both tissue mechanical properties and microarchitectural parameters. Morphologie. 101, 88-96, 2017.

5. INSALACO P, LEGRAND E, BOUVARD B, AUDRAN M. Osteoporosis in Stickler syndrome. A new family case with bone histology study. Morphologie. 101, 33-38, 2017.

6. KÜN-DARBOIS J.D., GUILLAUME B., CHAPPARD D. Asymmetric bone remodeling in mandibular and maxillary tori. Clin. Oral Invest. 21, 2781-2788, 2017.

7. KÜN-DARBOIS J.D., MANERO F., RONY L., CHAPPARD D. Contrast enhancement with uranyl acetate allows quantitative analysis of the articular cartilage by microCT: application to mandibular condyles in the BTX rat model of disuse. Micron, 97, 35-40, 2017.

8. LESPESSAILLES E, CORTET B, LEGRAND E, GUGGENBUHL P, ROUX C. Low-

trauma fractures without osteoporosis. Osteoporos Int. 28, 1771-1778, 2017.

9. LIBOUBAN H., CHAPPARD D. Altered bone remodeling due to dietary calcium deficiency increases osteolysis and modifies gene expression profile in a mouse model of myeloma. Micron 96, 77-85, 2017.

10. MABILLEAU G. Interplay between bone and incretin hormones: A review. Morphologie.

101, 9-18, 2017.

11. PASCARETTI-GRIZON F., GUILLAUME B., TERRANOVA L., ARBEZ B., LIBOUBAN H., CHAPPARD D. Maxillary sinus lift with beta tricalcium phosphate (β-TCP) in edentulous patients: a nanotomographic and Raman study. Calcified Tissue Int. 101, 280-290, 2017.

12. TERRANOVA L., DRAGUSIN D.M., MALLET R., VASILE E., STANCU I.C., BEHETS C.,

CHAPPARD D. Repair of calvarial bone defects in mice using electrospun polystyrene scaffolds combined with β-TCP or gold nanoparticles. Micron, 93, 29-37, 2017.

- 2016 -

1. BOUVARD B., MASSON C., LEGRAND E., AUDRAN M. Fibrodysplasia ossificans

progressiva. A case report and focus on the BMP signaling pathway. Morphologie, accepté

définitivement. Morphologie 100, 250-255, 2016.

2. CHAPPARD D. Effects of Aluminum on cells and tissues. Editorial Morphologie. 100, 49-

50, 2016.

Page 5: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 5 -

3. CHAPPARD D., BIZOT P., MABILLEAU G., HUBERT L. Aluminum and bone: review of

new clinical circumstances associated with Al3+ deposition in the calcified matrix of bone. Morphologie. 100, 95-105, 2016.

4. CHAPPARD D, LIBOUBAN H. Vector analysis of porosity evidences bone loss at the

epiphysis in the BTX rat model of disuse osteoporosis. J. Anat. Soc Ind. 65, 3-8, 2016.

5. CHAPPARD, D., TERRANOVA, L., MALLET, R., & MERCIER, P. in: “Salmon P., Chappard

D., Pitsillides A (eds)”. A Putting the "why" back into bone "archytecture". Frontiers ebook

en open access, 2016. pp 75-82, ISSN 1664-8714; ISBN 978-2-88919-311-0; DOI

10.3389/978-2-88919-311-0

6. CREN JB, BOUVARD B, CROCHETTE N. Cerebral toxoplasmosis and anti-TNFα: a case report. IDCases. 5, 40-2, 2016

7. DOYARD M., CHAPPARD D., LEROYER P. ROTH MP. LORÉAL O., GUGGENBUHL P.

Decreased bone formation explains osteoporosis in a genetic mouse model of

hemochromatosis. PlosOne 11(2): e0148292. doi:10.1371/journal.pone.0148292, 2016.

8. DUPONT V, ROUGÉ-MAILLART C, GAUDIN A, JEANNETEAU A, JOUSSET N, MALBRANQUE S. Left Diaphragm Laceration Due to Cardiopulmonary Resuscitation. J.

Forensic Sci. 61, 1135-38, 2016.

9. GUILLAUME B. Dental implants: a review. Morphologie, 100, 189-98, 2016.

10. LIBOUBAN H., PASCARETTI-GRIZON F., CAMPRASSE G., CAMPRASSE S.,

CHAPPARD D. In vivo erosion of orthopedic screws prepared from nacre (mother of pearl).

Orthop. Traumatol. Surg. Res. 102, 913–918, 2016. Version Française : Erosion in vivo de

vis orthopédiques préparées à partir de la nacre d’huitre perlière. Rev. Chir Orthoped.

Traumatol. 102, 657–662, 2016.

11. MABILLEAU G., PERROT R., FLATT P. R., IRWIN N., CHAPPARD D. High fat-fed diabetic

mice present with profound alterations of the osteocyte network. Bone, 90, 99-106, 2016

12. MABILLEAU G., PERROT R., MIECZKOWSKA A., BONI S., FLATT P.R., IRWIN N.,

CHAPPARD D. Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently

reduces osteoclast differentiation and resorption. Bone, 91, 102-12, 2016.

13. MANSUR S.A., MIECZKOWSKA A., FLATT P.R, BOUVARD B., CHAPPARD D., IRWIN

N., MABILLEAU G. A new stable GIP-Oxyntomodulin hybrid peptide improved bone

strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus.

Bone. 87, 102-113, 2016.

14. ROUGÉ-MAILLART C, JOUSSET N, BACCINO E. Scientific research on cadavers in

connection with a forensic autopsy: For a legislative amendment. Rev. Med. Légale. 7,

127-31, 2016.

Page 6: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 6 -

15. ROUGÉ-MAILLART C, DUPONT V, JOUSSET N. The problem with medical research on

tissue and organ samples taken in connection with forensic autopsies in France. J.

Forensic Legal Med. 38, 6-10, 2016.

16. TERRANOVA L., MALLET R., PERROT R., CHAPPARD D. Polystyrene scaffolds based

on microfibers as a bone substitute; development and in vitro study. Acta Biomater. 29,

380-388, 2016.

17. SARRE ME, ANNWEILER C, LEGRAND E, MARTIN L, BEAUCHET O. Association

between bullous pemphigoid and hypovitaminosis D in older inpatients: Results from a

case-control study. Eur J Intern Med. 31, 25-28, 2016.

18. SOUBERBIELLE JC, BENHAMOU CL, CORTET B, ROUSIÈRE M, ROUX C, ABITBOL V,

ANNWEILER C, AUDRAN M, BACCHETTA J, BATAILLE P, BEAUCHET O, BARDET R,

BENACHI A, BERENBAUM F, BLAIN H, BORSON-CHAZOT F, BREUIL V, BRIOT K,

BRUNET P, CAREL JC, CARON P, CHABRE O, CHANSON P, CHAPURLAT R, COCHAT

P, COUTANT R, CHRISTIN-MAITRE S, COHEN-SOLAL M, COMBE C, CORMIER C,

COURBEBAISSE M, DEBRUS G, DELEMER B, DESCHENES G, DUQUENNE M, DUVAL

G, FARDELLONE P, FOUQUE D, FRIEDLANDER G, GAUVAIN JB, GROUSSIN L,

GUGGENBUHL P, HOUILLIER P, HANNEDOUCHE T, JACOT W, JAVIER RM, JEAN G,

JEANDEL C, JOLY D, KAMENICKY P, KNEBELMANN B, LAFAGE-PROUST MH,

LEBOUC Y, LEGRAND E, LEVY-WEIL F, LINGLART A, MACHET L, MAHEU E, MALLET

E, MARCELLI C, MARÈS P, MARIAT C, MARUANI G, MAUGARS Y, MONTAGNON F,

MOULIN B, ORCEL P, PARTOUCHE H, PERSONNE V, PIERROT-DESEILLIGNY C,

POLAK M, POUTEIL-NOBLE C, PRIÉ D, RAYNAUD-SIMON A, ROLLAND Y, SADOUL

JL, SALLE B, SAULT C, SCHOTT AM, SERMET-GAUDELUS I, SOUBRIER M, TACK I,

THERVET E, TOSTIVINT I, TOURAINE P, TREMOLLIÈRES F, URENA-TORRES P,

VIARD JP, WEMEAU JL, WERYHA G, WINER N, YOUNG J, THOMAS T. French law:

what about a reasoned reimbursement of serum vitamin D assays? Geriatr Psychol

Neuropsychiatr Vieil. 377-382, 2016.

- 2015 -

1. ABED E., BOUVARD B., MARTINEAU X., JOUZEAU J.Y., REBOUL P., LAJEUNESSE D.

Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their

altered response to bone morphogenetic protein-2 and reduced mineralization capacity.

Bone. 75, 111-119, 2015

2. AGUADO E., PASCARETTI-GRIZON F., GOYENVALLE E., AUDRAN M., CHAPPARD D. Bone mass and bone quality are altered by hypoactivity in the chicken. PlosOne.

DOI:10.1371/journal.pone.0116763 January 30, 2015.

3. CHAPPARD D. Multiple myeloma and bone (Editorial). Morphologie, 99, 29-30, 2015.

4. CHAPPARD D., MABILLEAU G., MOUKOKO D., HENRIC N., STEIGER V., LE NAY P.,

FRIN J.M., DE BODMAN C. Aluminum and iron can be deposited in the calcified matrix of

bone exostoses. J. Inorg. Biochem. 152, 174-179, 2015.

Page 7: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 7 -

5. CHAPPARD D., STANCU I.C. Porosity imaged by a vector projection algorithm correlates

with fractal dimension measured on 3D models obtained by microCT. J. Microsc. 258, 24-

30, 2015.

6. CHAPPARD D., TERRANOVA L, MALLET R., MERCIER P. 3D distribution of granules of

a biomaterial (β-TCP) and bone by microCT and vector analysis of porosity. Front.

Endocrinol., Bone Research. DOI: 10.3389/fendo.2015.00161, 2015.

7. DEGUETTE C., CHAPPARD D., LIBOUBAN H., AIRAGNES G., ROUGE-MAILLART C.,

TELMON N. The contribution of Micro-CT to the evaluation of trabecular bone at the

posterior part of the auricular surface in men. Int J Legal Med. DOI: 10.1007/s00414-014-

1139-1 2015.

8. KÜN-DARBOIS J.D., LIBOUBAN H., CHAPPARD D. Botulinum toxin in masticatory

muscles of the adult rat induces bone loss at the condyle and alveolar regions of the

mandible associated with a bone proliferation at a muscle enthesis. Bone 7, 75-82, 2015. 2014 : 4.09

9. MABILLEAU G. Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility

fractures? Editorial Endocrine. 48, 1-2, 2015.

10. MABILLEAU G., MIECZKOWSKA A., CHAPPARD D. Glucose-dependent insulinotropic

polypeptide (GIP) directly affects collagen cross-linking and deposition in osteoblast

cultures. Bone 74, 29-36, 2015.

11. MABILLEAU G., MIECZKOWSKA A., LIBOUBAN H., SIMON Y., AUDRAN M.,

CHAPPARD D. Comparison between quantitative X-ray imaging, dual energy X-ray

absorptiometry and microCT in the assessment of bone mineral density in disuse-induced

bone loss. J. Musculoskelet Neuronal Interact, 15, 42-52, 2015.

12. MABILLEAU G., CHAPPARD D., FLATT P.R, IRWIN N Effects of anti-diabetic drugs on

bone metabolism. Expert Rev. Endocrinol. Metab. 10,663-675, 2015.

13. MANSUR L, MIECZKOWSKA A., BOUVARD B, FLATT P.R, IRWIN N, CHAPPARD D.,

MABILLEAU G., Stable incretin mimetics counter rapid deterioration of bone quality in type

1 diabetes mellitus. J. Cell. Physiol. 230, 3009–3018, 2015.

14. MASI L., AGNUSDEI D., BILEZIKIAN J., CHAPPARD D., CHAPURLAT R., CIANFEROTTI

L., DEVOLGELAER J-P., EL MAGHRAOUI A., FERRARI S., JAKOB F., JAVAID K.,

KAUFMAN J-M., LIBERMAN U., LYRITIS G., MILLER P., NAPOLI N., ROLDAN E.

PAPAPOULOS S., WATTS N.B., BRANDI M.L. Taxonomy of rare congenital metabolic

bone disorders. Osteoporosis Int. 26, 2529-2558, 2015. + erratum 26, 2717-2718

15. MIECZKOWSKA A., MANSUR S., FLATT P.R., THORENS B., IRWIN N., CHAPPARD D.

MABILLEAU G. Double incretin receptor knock-out (DIRKO) mice present with alterations

Page 8: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 8 -

of trabecular and cortical micromorphology and bone strength Osteoporosis Int 26, 209-

218, 2015.

16. MIECZKOWSKA A., MANSUR S.A., IRWIN N., FLATT P., CHAPPARD D., MABILLEAU

G. Alteration of the bone tissue material properties in type 1 diabetes mellitus: a Fourier-

transform infrared microspectroscopy study. Bone, 76, 31-39, 2015.

17. N’DIAYE M., LIBOUBAN H., AGUADO E., AUDRAN M., CHAPPARD D. Unwrapping

microcomputed tomographic images for measuring cortical osteolytic lesions in the 5T2

murine model of myeloma treated by bisphosphonate. Micron, 68, 107-114, 2015.

18. N’DIAYE M., TERRANOVA L., MALLET R., MABILLEAU G., CHAPPARD D. Three-

dimensional arrangement of β-tricalcium phosphate granules evaluated by microcomputed

tomography and fractal analysis. Acta Biomater 11, 404-411, 2015.

19. PIOT J.M. ROYER M., SCHMIDT-TANGUY A., HOPPÉ H., GARDEMBAS M., BOURRÉE

T., HUNAULT M., FRANÇOIS S., BOYER F., IFRAH N., RENIER G., CHEVAILLER A,

AUDRAN A., CHAPPARD D., LIBOUBAN H., LEGRAND E., MABILLEAU G. BOUVARD

B. Factors associated with an increased risk of vertebral fracture in monoclonal

gammopathies of undetermined significance. Blood Cancer J. 2015 Aug 28;5:e345

20. TERRANOVA L, LIBOUBAN H., MALLET R. CHAPPARD D. Analysis of β-TCP granules

prepared with different formulations by nano computed tomography and scanning electron

microscopy. J. Artific. Organs 18, 338-345, 2015.

- 2014 -

1. AGUADO E., GAUDIN-AUDRAIN C., GOYENVALLE E., PASCARETTI-GRIZON F.,

CHAPPARD D. β-TCP granules mixed with reticulated hyaluronic acid induce an increase in bone apposition. Biomed. Mater. 9, 015001.doi:10.1088/1748-6041/9/1/015001, 2014.

2. BOUVARD B., SOULIÉ P., HOPPÉ E., GEORGIN-MEGE M., ROYER M.,

MESGOUEZNEBOUT N., LASSALLE C., CELLIER P., JADAUD E., ABADIE-

LACOURTOISIE S., TUCHAIS C., VINCHON-PETIT S., AUDRAN M., CHAPPARD D.,

LEGRAND E. Fracture incidence after 3 years of aromatase inhibitor therapy. Ann. Oncol.

25, 843-847, 2014

3. BOUVARD B, LEGRAND E. The dilemmas of breast cancer treatment and increased

fracture risk' by Malik. Ann Oncol. 25, 1664-5, 2014.

4. DEMAIS V., AUDRAIN C., MABILLEAU G., CHAPPARD D., BASLE M.F. Diversity of bone

matrix adhesion proteins modulates osteoblast attachment and organization of actin

cytoskeleton. Morphologie 98, 53-64, 2014.

Page 9: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 9 -

5. MABILLEAU G., MIECZKOWSKA A., CHAPPARD D., The use of glucagon-like peptide-1

receptor agonists and bone fractures. A meta-analysis of randomized clinical trials. J.

Diabetes, 6, 260–266, 2014.

6. MABILLEAU G., MIECZKOWSKA A., IRWIN N., AUDRAN M., FLATT P.R., CHAPPARD D.

Beneficial effects of N-AcGIP on bone material properties. Bone 63, 61-68, 2014.

7. PASCARETTI-GRIZON F., LIBOUBAN H., CAMPRASSE G., CAMPRASSE S., MALLET

R., CHAPPARD D. The interface between nacre and bone after implantation in the sheep:

a nanotomographic and Raman study. J. Raman Spectr. 45, 558–564, 2014

8. SERAFIM A., MALLET R., PASCARETTI-GRIZON F., STANCU I.C., CHAPPARD D.

Porous scaffolds based on poly(styrene) fibers with bone regeneration potential. BioMed

Res. Int. ID 609319, doi.org/10.1155/2014/609319, 2014

Page 10: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 10 -

- 2013 -

1. AUDRAN M., JAKOB F. J., PALACIOS S., BRAND M.-L., I H. BRÖLL, HAMDY N. A. T.,

MCCLOSKEY E. V. A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3 years. Rheumatol. Int. 33, 2231-2239, 2013.

2. BENAMEUR T., CHAPPARD D., FIOLEAU E, ANDRIANTSITOHAINA R, MARTINEZ M.C.,

MARCHAND-LIBOUBAN H. Involvement of membrane microparticles in a mouse model of

multiple myeloma. Micron, 54-55, 75-81, 2013.

3. BEUVELOT, J., FILMON R., MAURAS Y., BASLE M.F., CHAPPARD D. N Adsorption and

release of strontium from hydroxyapatite crystals developed in Simulated Body Fluid (SBF)

on poly (2-hydroxyethyl) methacrylate substrates. Dig. J. Nanomater. Biostruct.. 8, 207 -

217, 2013.

4. BOUVARD B., GALLOIS Y., LEGRAND E., BASLE M.F. AUDRAN M., CHAPPARD D.

Glucocorticoids reduce alveolar bone at the mandible in mice. Joint Bone Spine 80, 77-81, 2013.

5. CHAPPARD D., MARCHAND-LIBOUBAN H., MOREAU M.F., BASLE M.

Thiazolidinediones cause compaction of nuclear heterochromatin in the pluripotent mesenchymal cell line C3H10T1/2 when inducing an adipogenic phenotype. Anal. Quant.

Cytol. Histol. 35, 85-94, 2013.

6. CHAPPARD D. Modelage et remodelage au cours de l’ostéointégration. Rev. Stomatol.

Chir. Maxillo-Fac. Chir. Oral. 114, 159-165, 2013.

7. DEGERATU C.N., MABILLEAU G., CINCU C., CHAPPARD D. Aluminum inhibits the growth

of hydroxyapatite crystals developed on a biomimic methacrylic polymer. J. Trace Elem.

Med. Biol,4, 3, 346-351, 2013

8. GAUDIN-AUDRAIN C., IRWIN N., MANSUR S., FLATT P.R., THORENS B., BASLE M.,

CHAPPARD D., MABILLEAU G. Glucose-dependent insulinotropic polypeptide receptor

deficiency leads to modifications of trabecular bone mass and quality in mice. Bone 53, 221-

230.

9. HOPPE E, BOUVARD B, ROYER M, CHAPPARD D, AUDRAN M, LEGRAND E. Is

androgen therapy indicated in men with osteoporosis? Joint Bone Spine. 80, 459-65, 2013.

10. KAUFMAN J.-M., M. AUDRAN, G. BIANCHI, V. BRAGA, M. DIAZ-CURIEL, R. M. FRANCIS,

S. GOEMAERE, R. JOSSE, S. PALACIOS, J. D. RINGE, D. FELSENBERG, AND S.

BOONEN. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.

J Clin. Endocrinol. Metab, 98, 592–601, 2013

11. KOUFANY M., MOULIN D., MAIRE T., NETTER P., WERYHA G., CHAPPARD D.,

JOUZEAU J.Y. The Peroxisome Proliferator-Activated Receptor gamma (PPARγ) agonist

Page 11: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 11 -

pioglitazone preserves bone micro-architecture in experimental arthritis. Arthrit. Rheumat.

65, 3084—3095, 2013.

12. MABILLEAU G., MIECZKOWSKA A., IRWIN N., FLATT P.R., CHAPPARD D. Optimal bone strength requires a functional glucagon-like peptide-1 receptor. J. Endocr. 219, 59-68, 2013.

13. MABILLEAU G., MIECZKOWSKA A., CHAPPARD D., The use of glucagon-like peptide-1

receptor agonists and bone fractures. A meta-analysis of randomized clinical trials. J.

Diabetes, 6, 260-266, 2014.

14. MALLARD F., BOUVARD B., MERCIER P., BIZOT P., CRONIER P., CHAPPARD D.

Trabecular microarchitecture in established osteoporosis: relationship between vertebrae,

distal radius and calcaneus by texture analysis of X-ray images. / Version française : Micro-

architecture trabéculaire dans l’ostéoporose confirmée : relations entre vertèbres, radius distal et calcanéus au moyen de l’analyse de texture d’images radiographiques. Rev. Chir.

Orthop. Traumatol. 99, 34-42, 2013. Orthop.Traumatol. Surg. Res. 99, 52–59, 2013.

15. MALLARD F, JEUDY J, RABARIN F, RAIMBEAU G, FOUQUE PA, CESARI B, BIZOT P,

SAINTCAST Y. Reverse wedge osteotomy of the distal radius in Madelung's deformity.

Orthop Traumatol Surg Res. 99, S279-83, 2013.

16. MARCHAND-LIBOUBAN H., GUILLAUME B., BELLAICHE N., CHAPPARD D. Texture

analysis of computed tomographic images in osteoporotic patients with sinus lift bone graft

reconstruction. Clin. Oral Invest. 17, 1267–1272, 2013

17. MARCHAND-LIBOUBAN H., LE DREVO M.A., BASLE M., CHAPPARD D. Disuse induced

by botulinum toxin affects the expression profile of osteoblastic and resorption genes leading

to a rapid bone loss. J. Musculoskel. Neuron. Inter. 13, 27-36, 2013.

18. MATEUS-HAMDAN L, BEAUCHET O, BOUVARD B, LEGRAND E, FANTINO B,

ANNWEILER C. High parathyroid hormone, but not low vitamin D concentrations, expose

elderly inpatients to hypertension. Geriatr Gerontol Int. 13, 783-91, 2013

19. MIECZKOWSKA A., IRWIN N., FLATT P.R., CHAPPARD D., MABILLEAU G Glucose-

dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone

strengthand quality. Bone 56, 337-342, 2013.

20. N’DIAYE M., DEGERATU C., BOULER J.M., CHAPPARD D. Biomaterials porosity

determined by fractal dimensions, succolarity and lacunarity on microcomputed tomographic

images. Mater. Sci. Engin. C Mater Biol Appl. 33, 2025-2030, 2013.

21. PASCARETTI-GRIZON F., MABILLEAU G., CHAPPARD D. Abrasiveness of 6 dentifrices measured by vertical interference microscopy. J Appl. Oral Sci 21, 475-81, 2013.

22. RIZZOLI R., BODY J. J., BRANDI M. L., CANNATA-ANDIA J., CHAPPARD D., EL

MAGHRAOUI A., GLÜER C., KENDLER D., NAPOLI N., PAPAIOANNOU A., PIERROZ D.

D., RAHME M., VAN POSNAK C. H., de VILLIERS T. J., EL HAJJ FULEIHAN G. Cancer-

associated bone disease: a Position Paper from the International Osteoporosis Foundation

Page 12: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 12 -

Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease.

Osteoporosis Int. 24, 2929-53, 2013.

23. SAYEGH J., AUGUSTO J.F., CHAPPARD D., INSALACO P., SUBRA J.F. A case of severe

osteomalacia secondary to phosphate diabetes in a renal transplant recipient. Int. Urol.

Nephrol. 24, 2929-2953, 2013

24. VIEL T, CASIN C, DUCELLIER F, STEIGER V, BIGORRE N, BIZOT P. Is radiographic

measurement of distal femoral torsion reliable? Orthop. Traumatol. Surg. Res. 9, 517-22,

2013.

25. VENARA A., PAVAGEAU A.H., ROUGE-MAILLART C., JOUSSET N. Sudden death due to

black esophagus: a case Report. Am. J. Forensic Med. Pathol. 34, 16-17, 2013.

26. VENARA, A., MARTRILLE, L., GODIN, M., KERDAT, C., DEGUETTE, C., CHAPPARD, D.,

ROUGE-MAILLART, C. Estimation of skeletal age at death in adults using the acetabulum

and the auricular surface - An application on the Terry Collection. Rev. Med. Leg. 4, 189 –

196, 2013.

- 2012 -

1. AUDRAN M., MAURY E., BOUVARD B., LEGRAND E., BASLE M.F., CHAPPARD D. Is

transiliac bone biopsy a painful procedure? Clin. Nephrol., 77, 97-104, 2012.

2. AUDRAN M., CHAPPARD D. Rachitismes et ostéomalacies a l'age adulte (Rickets and osteomalacia in adults). Rev. Rhum. Monographie, 79, 248-252, 2012.

3. BODIC F., AMOURIQ Y., GAYET-DELACROIX M., MAUGARS Y., HAMEL L., BASLÉ M.F.,

CHAPPARD D. Relationships between mandibular and iliac bone mass and

microarchitecture in endentulated subjects: a DXA, CT and microCT study. Gerodontology,

29, e585-e594, 2012.

4. BOUVARD B., HOPPÉ E., SOULIÉ P., GEORGIN-MEGE M., JADAUD E.,

ABADIELACOURTOISIE S., PETIT LE MANAC'H A., LAFFITTE A., LEVASSEUR R.,

AUDRAN M., CHAPPARD D., LEGRAND E. High prevalence of vertebral fractures in

women with breast cancer starting aromatase inhibitor therapy. Ann. Oncol. 23, 1151-1156,

2012 I

5. BOUVARD B., MABILLEAU G., LEGRAND E., AUDRAN M., CHAPPARD D. Micro and

macroarchitectural changes at the tibia after botulinum toxin injection in the growing rat.

Bone. 50, 858-864, 2012. Une image de cet article a été sélectionnée pour illustrer la

couverture de la revue.

6. BREUIL V., CORTET B., COTTE F.E., ARNOULD B., DIAS-BARBOSA C., GAUDIN A.F.,

REGNAULT A., ROBOREL DE CLIMENS A., LEGRAND E. Validation of the adherence

evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-

menopausal women. Osteoporosis Int. 23, 445-455, 2012.

Page 13: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 13 -

7. BRIOT K., CORTET B., THOMAS T., AUDRAN M., BLAIN H., BREUIL V., CHAPUIS L.,

CHAPURLAT R., FARDELLONE P., FERON J.M., GAUVAIN J.B., GUGGENBUHL P.,

KOLTA S., LESPESSAILLES E., LETOMBE B., MARCELLI C., ORCEL P., SERET P.,

TRÉMOLLIÈRES F., ROUX C. 2012 update of French guidelines for the pharmacological

treatment of postmenopausal osteoporosis. Joint Bone Spine. 79, 304-13, 2012.

8. CORVAISIER M., DELNESTE Y., JEANVOINE H., PREISSER L., BLANCHARD S., GARO

E., HOPPE E., BARRE B., AUDRAN M., BOUVARD B., SAINT-ANDRE J.P., JEANNIN P.

IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine

production and Th17 cell generation. PLoS Biol.; 10, e1001395, 2012.

9. DEPREZ P., NICHANE M., ROUSSEAUX P., DEVOGELAER J.P., CHAPPARD D.,

LENGELÉ B., REZSÖHAZY R., NYSSEN-BEHETS C. Postnatal growth defect in mice upon

persistent Hoxa2 expression in the chondrogenic cell lineage. Differentiation 83, 158-167,

2012.

10. GUILLARD C., LINTZ, F., ODRI, G., VOGELI, D., COLIN, F., COLLON, S., CHAPPARD,

D., GOUIN, F., ROBERT, H. Effects of graft pretensioning in anterior cruciate ligament

reconstruction. Knee Surg. Sports Traumatol. Arthrosc. 1833-1841, 2012.

11. GUILLAUME G., AUDRAN M., CHAPPARD D. Evaluation of the bone status in high level

cyclists. J. Clin. Densitom. 15, 103-107, 2012.

12. JEUDY J., STEIGER V., BOYER P., CRONIER P., BIZOT P., MASSIN P. Treatment of

complex fractures of the distal radius: a prospective randomised comparison of external

fixation 'versus' locked volar plating. Injury, 43, 174-179, 2012.

13. LE CORRE Y., LE SAUX O., FROELIGER F., LIBOUBAN H., KAUFFENSTEIN G.,

WILLOTEAUX S., LEFTHERIOTIS G., MARTIN L. Quantification of the calcification

phenotype of Abcc6-deficient mice with microcomputed tomography. Am. J. Pathol., 180,

2208-2213, 2012.

14. MABILLEAU G., CHAPPARD D., BASLE M.F. Depth and volume of resorption induced by

osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT. Cytokine 57,

294-299, 2012.

15. MASSON C. Therapeutic approach to giant cell arteritis. Joint Bone Spine, 79, 219-227,

2012.

16. MATEUS-HAMDAN L., BEAUCHET O., BOUVARD B., LEGRAND E., FANTINO B.,

ANNWEILER C. High parathyroid hormone, but not low vitamin D concentrations, expose

elderly inpatients to hypertension. Geriatr Gerontol Int. doi: 10.1111/j.1447-

0594.2012.00945.x, 2012.

Page 14: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 14 -

17. MIECZKOWSKA A., BASLÉ M.F., CHAPPARD D., MABILLEAU G. Thiazolidinediones

induced osteocyte apoptosis by a GPR40-dependent mechanism. J. Biol. Chem. 6, 287,

23517-26, 2012.

18. N’DIAYE M., PASCARETTI-GRIZON F., MASSIN P., BASLÉ M.F., CHAPPARD D. Water

absorption of poly (methylmethacrylate) measured by vertical interference microscopy.

Langmuir, 28, 11609-11614, 2012

19. PINAR N., VERNET E., BIZOT P., BRILHAULT J. Total ankle arthroplasty - total ankle

arthroplasty in Western France: influence of volume on complications and clinical outcome.

Orthop. Traumatol. Surg. Res., 98, 26-30, 2012.

20. ROYER M., THOMAS T., CESINI J., LEGRAND E. Stress fractures in 2011: practical

approach. Joint Bone Spine, 79, 86-90, 2012.

-2011-

1. APARD T., CASIN C., MOUBARAK E., BIZOT P. A novel pyrolytic carbon implant for hallux

rigidus: a cadaveric study. Foot Ankle Surg. 17, 182-185, 2011.

2. AUDRAN M., CHAPPARD D. Hypophosphatasie : diagnostic et conduite a tenir. Rev. Rhum.

monographies 78, 267–273, 2011.

3. AUDRAN M., CORTET B., THOMAS T. What do we know about atypical femoral fractures?

insights and enigmas. Joint Bone Spine. 78, 568-571, 2011.

4. BEUVELOT J., PASCARETTI-GRIZON F., FILMON R., MOREAU M-F., BASLE M.F.,

CHAPPARD D. In vitro assessment of osteoblast and macrophage mobility in presence of

β-TCP particles by videomicroscopy. J. Biomed. Mater. Res. -A. 96, 108-15, 2011.

5. BOUVARD B., ROYER M., CHAPPARD D., AUDRAN M., HOPPÉ E., LEGRAND E. Extraskeletal effects of vitamin D: Facts, uncertainties, and controversies. Joint Bone Spine,

78, 10-16, 2011.

6. CHAPPARD D., BASLE M.F., LEGRAND E., AUDRAN M. New laboratory tools in the

assessment of bone quality. Osteoporosis Int. 22, 2225–2240, 2011.

7. CORTET B., BIVER E., BORG S., CHOPIN F., HOPPE E., LAROCHE M., MOREL G.,

LEGRAND E. Management of male osteoporosis: lessons for clinical practice. Rev. Rhum.

78, 208-210, 2010.

8. DACULSI G., GOYENVALLE E., COGNET R., AGUADO E., SUOKAS E. O.

Osteoconductive properties of poly(96L/4D-lactide)/beta-tricalcium phosphate in long term

animal model. Biomaterials 32, 3166-3177, 2011.

Page 15: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 15 -

9. FANTINO B., BEAUCHET O., SAVIGNAT S., BOUVARD B., LEGRAND E., ANNWEILER

C. profile of French community-dwelling older adults supplemented with vitamin d: findings and lessons. Adv Ther, 28, 483-489, 2011.

10. GEOFFROY V., CHAPPARD D., MARTY C., LIBOUBAN H., OSTERTAG A., LALANDE A.,

DE VERNEJOUL M.C. Strontium ranelate decreases the incidence of new caudal vertebral

fractures in a growing mouse model with spontaneous fractures by improving bone

microarchitecture. Osteoporosis Int. 22, 289-297, 2011.

11. GEOFFROY V., PASCHALIS P., LIBOUBAN H., BLOUIN S., OSTERTAG A., CHAPPARD

D., CROS M., PHIPPS R., DE VERNEJOUL M.C. Effects of risedronate in runx2 over-

expressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. Calcif. Tissue Int. 88, 464-473, 2011.

12. GUGGENBUHL P., FERGELOT P., DOYARD M., LIBOUBAN H., ROTH P.M., GALLOIS Y.,

CHALÈS G., LORÉAL O., CHAPPARD D. Bone Status in a mouse model of genetic

hemochromatosis. Osteoporosis Int. 22, 2313-2319, 2011.

13. MABILLEAU G., CHAPPARD D., BASLE M.F. Skeletal phenotype observed with

thiazolidinediones: cellular and molecular mechanisms. Int. J. Biochem. Mol. Biol. 2, 240-

246, 2011.

14. MABILLEAU G., CHAPPARD D., SABOKBAR A. Role of the A20-TRAF6 axis in

lipopolysaccharide-mediated osteoclastogenesis. J. Biol. Chem. 4,286, 3242-3249

15. MASSON C. Rheumatoid anemia. Joint Bone Spine. 78, 131-7, 2011.

16. NYANGOGA H., MERCIER P., LIBOUBAN H., BASLÉ M.F., CHAPPARD D. Three-

dimensional characterization of the vascular bed in metastatic bone of rat. PlosOne 28; 6,

e17336, 2011.

17. PASCARETTI-GRIZON F., MABILLEAU G., BASLE M.F., C HAPPARD D. Measurement by

vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts

on dentine slices. J. Microscopy. 241, 147-152, 2011

18. RAMOND A., BOUTON C., RICHARD I., ROQUELAURE Y., BAUFRETON C., LEGRAND

E., HUEZ J.F. Psychosocial risk factors for chronic low back pain in primary care-a

systematic review. Fam Pract. 28, 12-21, 2011.

19. ROCHE-LEBOUCHER G., PETIT-LEMANAC'H A., BONTOUX L., DUBUS-BAUSIERE V.,

PAROT-SHINKEL E., FANELLO S., PENNEAU-FONTBONNE D., FOUQUET N.,

LEGRAND E., ROQUELAURE Y., RICHARD I. multidisciplinary intensive functional

restoration versus outpatient active physiotherapy in chronic low back pain: a randomized

controlled trial. Spine, 5, 36, 2235-2242, 2011.

Page 16: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 16 -

-2010-

1. ANNWEILER C., POCHIC S., FANTINO B., LEGRAND E., BATAILLE R., MONTERO-

ODASSO M., BEAUCHET O. Serum vitamin D concentration and short-term mortality among geriatric inpatients in acute care settings. Adv Ther. 27, 245-9, 2010.

2. APARD T., BIGORRE N., CRONIER P., DUTEILLE F., BIZOT P., MASSIN P. Two-stage

reconstruction of post-traumatic segmental tibia bone loss with nailing. Orthop Traumatol

Surg Res. 96, 549-53, 2010.

3. APARD T., DUCELLIER F., HUBERT L., TALHA A., CRONIER P., BIZOT P. Isolated

interfragmentary compression for nonunion of humeral shaft fractures initially treated by

nailing: A preliminary report of seven cases. Injury. 41, 1262-5, 2010.

4. AUDRAN M., BRIOT K. Critical reappraisal of vitamin D deficiency. Joint Bone Spine 77,

115-119, 2010.

5. BEUVELOT J., BERGERET C., MALLET R., COUSSEAU J., BASLÉ M.F., CHAPPARD D.

In vitro calcification of carbon nanotubes chemically functionalized. Acta Biomater 6, 4110-

4117, 2010

6. BOUVARD B., LEGRAND E., AUDRAN M., CHAPPARD D. Glucocorticoid-induced

osteoporosis: a review. Clin. Rev. Bone Miner. Metab. 8, 15–26, 2010.

7. BOUVARD B., ROYER M., CHAPPARD D., AUDRAN M., HOPPÉ E., LEGRAND E.

Monoclonal gammopathy of undetermined significance, multiple myeloma, and osteoporosis. Joint Bone Spine, 77, 144-148, 2010.

8. BOUVARD B, ANNVEILLER C., SALLÉ A., BEAUCHET O., CHAPPARD D., AUDRAN M.,

LEGRAND, E. Les effets extra-osseux de la vitamine D: faits, questions et controversies.

Rev. Rhum. 77S, A18–A25, 2010.

9. CHAPPARD D., GUILLAUME B., MALLET R., PASCARETTI-GRIZON F., BASLÉ M.F.,

LIBOUBAN H. Sinus lift augmentation and -TCP: a microCT and histologic analysis on

human bone biopsies. Micron, 41, 321-326, 2010.

10. CHAPPARD D., LIBOUBAN H., LEGRAND E., IFRAH, N., MASSON C., BASLÉ M.F.,

AUDRAN M. Computed microtomography of bone specimens for rapid analysis of bone

changes associated with malignancy. Anat. Rec. 293, 1125-1133, 2010.

11. CHAPPARD D., LIBOUBAN H., MINDEHOLM L., BASLÉ M.F., LEGRAND E., AUDRAN M.

The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated

patients. Microsc. Res. Techn. 73, 726-732, 2010.

Page 17: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 17 -

12. DACULSI G., UZEL A. P., WEISS P., GOYENVALLE E., AGUADO E. Developments in

injectable multiphasic biomaterials. The performance of microporous biphasic calcium phosphate granules and hydrogels. J Mater Sci: Mater Med 21, 855–86, 2010.

13. FARDELLONE P., CORTET B., LEGRAND E., BRESSE X., BISOT-LOCARD S.,

VIGNERON A. M., BERESNIAK A. Cost-effectiveness model of using zoledronic acid once

a year versus current treatment strategies in postmenopausal osteoporosis. Joint Bone

Spine 77, 53-57, 2010.

14. GOYENVALLE E., AGUADO E., PILET P., DACULSI G. Biofunctionality of MBCP ceramic

granules (TricOs) plus fibrin sealant (Tisseel) versus MBCP ceramic granules as a filler of

large periprosthetic bone defects: an investigative ovine study. J. Mater. Sci.-Mater. Med.

21, 19491958, 2010.

15. HOPPÉ E., BOUVARD B., ROYER M., AUDRAN M., LEGRAND E. Sex hormone-binding globulin in osteoporosis. Joint Bone Spine. 77, 306-12, 2010.

16. HOPPE E, MASSON C., AUDRAN M., DRILLON M., ANDREU M., SARAUX A.,

BERTHELOT J.M., MAUGARS Y., HMAMOUCHI I., MOREL J.. Whipple's disease

diagnosed during biological treatment for joint disease. Joint Bone Spine. 77, 335-9, 2010.

17. JEGOUX F., AGUADO E., COGNET R., MALARD O., MOREAU F., DACULSI G.,

GOYENVALLE E. Alveolar ridge augmentation in irradiated rabbit mandibles. J. Biomed.

Mater. Res. - Part A 93, 1519-1526, 2010.

18. JEGOUX F., GOYENVALLE E., COGNET R., MALARD O., MOREAU F., DACULSI G., AGUADO E. Mandibular segmental defect regenerated with macroporous biphasic calcium phosphate, collagen membrane, and bone marrow graft in dogs. Arch Otolaryngol Head Neck Surg 136, 971-978, 2010.

19. JEGOUX F., MALARD O., GOYENVALLE E., AGUADO E., DACULSI G. Radiation effects

on bone healing and reconstruction: interpretation of the literature. Oral Surg. Oral Med. Oral

Pathol. Oral Radiol. Endod. 109, 173-184, 2010.

20. LE MANAC'H A. P., ROUSSELET M. C., MASSIN P., AUDRAN M., LEVASSEUR R.

Extraspinal sciatica revealing late metastatic disease from parotid carcinoma. Joint Bone

Spine 77, 64-66, 2010.

21. LE MANAC'H AP, ROUSSELET MC, MASSIN P, AUDRAN M, LEVASSEUR R. Extraspinal

sciatica revealing late metastatic disease from parotid carcinoma. Joint Bone Spine. 77, 64-

6, 2010.

22. MABILLEAU G., FILMON R., PETROV P.K., BASLÉ M.F., SABOKBAR A., CHAPPARD D.

Cobalt, chromium and nickel affect hydroxyapatite crystal growth in vitro. Acta Biomater. 6,

15551560, 2010.

Page 18: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 18 -

23. NYANGOGA H., AGUADO E., GOYENVALLE E., BASLÉ M.F., CHAPPARD D. A non

steroidal anti inflammatory drug (ketoprofen) does not delay β-TCP bone graft healing. Acta

Biomater. 6, 3310–3317, 2010.

24. NYANGOGA H., BLOUIN S., LIBOUBAN H., BASLÉ M.F., CHAPPARD D. Single

pretreatment by zoledronic acid converts metastases from osteolytic to osteoblastic in the

rat. Microsc. Res. Techn. 73, 733-740, 2010.

25. RACINE AC, LEGRAND E, LEFEBVRE-LACOEUILLE C, HOPPE E, CATALA L,

SENTILHES L, DESCAMPS P. Treatment of endometriosis by aromatase inhibitors: efficacy

and side effects. Gynecol Obstet Fertil. 38, 318-23, 2010.

26. ROUX C., CONFAVREUX C. B., CORTET B., DAVID C., LEBOIME A., LAROCHE M.,

LEGRAND E., MARCELLI C., MEHSEN N., PACCOU J., THOMAS T. Severe osteoporosis: diagnosis and follow-up. Lessons for clinical practice. Joint Bone Spine 77 Suppl 2, S139-

141, 2010.

-2009-

1. BADRAOUI R., BLOUIN S, REBAI T., SAHNOUN Z, BASLE M.F., CHAPPARD D. Effect of

alpha tocopherol acetate in Walker 256 cells-induced oxidative damage in a rat model of

breast cancer skeletal metastases. Chem-Biol. Interactions. 182, 98–105, 2009.

2. BAROTH S., BOURGES X., GOYENVALLE E., AGUADO E., DACULSI G. Injectable

biphasic calcium phosphate bioce ramic: The HYDROS concept. Biomed. Mater. Eng. 19,

71-76, 2009.

3. BEUVELOT J., PORTET D., LECOLLINET G., MOREAU M.F., BASLE M.F., CHAPPARD

D., LIBOUBAN H. In vitro kinetic study of growth and mineralization of osteoblast-like cells

(SaOS2) on titanium surface coated with a RGD functionalized bisphosphonate. J. Biomed.

Mater. Res –Appl. Biomat. B 90, 873-881, 2009.

4. BOUVARD B., AUDRAN M., LEGRAND E., CHAPPARD D. Ultrastructural characteristics

of glucocorticoid-induced. Osteoporosis. Int. 20, 1089-1092, 2009.

5. BRIOT K., AUDRAN M., CORTET B., FARDELLONE P., MARCELLI C., ORCEL P.,

VELLAS B., THOMAS T., ROUX C. Vitamin D: skeletal and extra skeletal effects;

recommendations for good practice. Presse Med 38, 43-54, 2009

6. BRIOT K., CORTET B., TREMOLLIERES F., SUTTER B., THOMAS T., ROUX C., AUDRAN

M. Male osteoporosis: Diagnosis and fracture risk evaluation. Joint Bone Spine. 76, 129-

133, 2009.

7. CHAPPARD D. Technical aspects: how do we best prepare bone samples for proper

histological analysis? In: Heymann D, editor. “Bone cancer: progression and therapeutic

approaches”. London: Acad. Press. Elsevier Inc. p 203-210, 2009.

Page 19: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 19 -

8. DUMAS A., BRIGITTE M., MOREAU M.F., CHRETIEN F., BASLÉ M. F. CHAPPARD D.

Bone mass and microarchitecture of irradiated and bone marrow-transplanted mice: influences of the donor strain. Osteoporosis Int. 20, 435-443, 2009.

9. DUMAS A., MOREAU M.F., GHÉRARDI R.K, BASLÉ M. F. CHAPPARD D. Bone grafts

cultured with bone marrow stromal cells for the repair of critical bone defects: An

experimental study in mice. J Biomed. Mater. Res. -A. 90, 1218-1229, 2009.

10. EASTELL R., NICKELSEN T. , F. MARIN, C. BARKER, P. HADJI, J. FARRERONS,

AUDRAN M., S. BOONEN, K. BRIXEN, J. MELO GOMES, B. OBERMAYER-PIETSCH, A.

AVRAMIDIS, G. SIGURDSSON, C. C. GLÜER Sequential Treatment of Severe

Postmenopausal Osteoporosis Following Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS). J. Bone Miner. Res. 24, 726-736,

2009.

11. FERRANT O., ROUGE-MAILLART C., GUITTET L., PAPIN F., CLIN B., FAU G., TELMON

N. Age at death estimation of adult males using coxal bone and CT scan: A preliminary

study. Foren. Sci. Int.186, 14-21, 2009.

12. FILMON R., RETAILLEAU-GABORIT N., BROSSARD G., GRIZON-PASCARETTI F.,

BASLÉ M.F., CHAPPARD D. Preparation of β-TCP granular material by polyurethane foam

technology. Image Anal. Stereol. 28:1-10, 2009.

13. GUILLAUME B, GAUDIN C, GEORGEAULT S, MALLET R, BASLÉ MF, CHAPPARD D.

Viability of osteocytes in bone autografts harvested for dental implantology. Biomed. Mater.

4, article n° 015012, 2009.

14. IDRIS A., LIBOUBAN H., NYANGOGA H, LANDAO-BASSONGA E., CHAPPARD D.,

RALSTON S.H. Pharmacological inhibitors of IKK inhibit growth and migration of breast

cancer cells in vitro and prevent osteolytic bone metastasis in vivo. Mol. Cancer Ther. 8,

2339-2347, 2009.

15. JEGOUX F., GOYENVALLE E., COGNET R., MALARD O., MOREAU F., DACULSI G.,

AGUADO E. Reconstruction of irradiated bone segmental defects with a biomaterial

associating MBCP+(R), microstructured collagen membrane and total bone marrow grafting:

an experimental study in rabbits. J. Biomed. Mater. Res. - Part A 91, 1160-1169, 2009.

16. JOSSELIN N., LIBOUBAN H., DIB M., IFRAH N., LEGRAND E., BASLÉ M.F., AUDRAN M.,

CHAPPARD D. Quantification of dendritic cells and osteoclasts in the bone marrow of

patients with monoclonal Gammopathy. Pathol. Oncol. Res., 15, 65–72, 2008

17. LEVASSEUR R. Bone tissue and hyperhomocysteinemia. Joint Bone Spine. 76, 234-240,

2009.

Page 20: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 20 -

18. LIBOUBAN H., FILMON R., MAUREAC A., BASLE M.F., CHAPPARD D. Fetuin and

osteocalcin interact with calcospherite formation during the calcification process of poly (2hydroxyethylmethacrylate) in vitro. J. Raman Spectrosc., 40, 1234-1239, 2009.

19. LIBOUBAN H., MASSIN P., GAUDIN C, MERCIER P., BASLE, M.F., CHAPPARD D.

Migration of wear debris of polyethylene depends of bone microarchitecture. J. Biomed.

Mater. Res –Appl. Biomat. B 90, 730-737, 2009.

20. NYANGOGA H., ZECHERU T., FILMON R., BASLÉ M.F., CINCU C., CHAPPARD D.

Synthesis and use of pHEMA microbeads with human EA.hy 926 endothelial cells. soumis

à J. Biomed. Mater. Res –Appl. Biomat. B 89, 501-507, 2009

21. OSTERTAG A., COHEN-SOLAL M., AUDRAN M., LEGRAND E., MARTY C., CHAPPARD

D. DE VERNEJOUL M.C. Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis. Bone 44, 413-417, 2009

22. POTIER A., LAVIGNE C., CHAPPARD D., VERRET J.L., CHEVAILLER A., NICOLIE B.,

DROUET M. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis:

Relationship to basal serum tryptase. Clin. Exp. Allerg. 39, 717-725, 2009.

23. ROUGÉ-MAILLART C, VIELLE B, JOUSSET N, CHAPPARD D, TELMON N, CUNHA E.

Development of a method to estimate skeletal age at death in adults using the acetabulum

and the auricular surface on a Portuguese population. Forensic Sci. Int. 188, 91-95, 2009.

24. ZECHERU T, FILMON R, RUSEN E, MĂRCULESCU B, ZERROUKHI A, CINCU C,

CHAPPARD D. Biomimetic potential of some methacrylate-based copolymers: A

comparative study. Biopolymers. 91, 966-973, 2009.

25. ZHANG H, DENG X, CIANCIULLI TF, ZHANG Z, CHAPPARD D, LAX JA, SACCHERI MC,

REDRUELLO HJ, JORDANA JL, PREZIOSO HA, KING M, GUIDOIN R. Clinical device-

related article pivoting system fracture in a bileaflet mechanical valve: A case report. J

Biomed Mater Res B Appl Biomater. 90, 952–961, 2009.

- 2008 -

1. BLOUIN S., BASLÉ M.F., CHAPPARD D. Interactions between microenvironment and

cancer cells in two animal models of bone metastasis. Brit. J. Cancer. 98, 809-815, 2008.

2. BLOUIN S., LIBOUBAN H, MOREAU MF, CHAPPARD D. ORX models of osteoporosis.

In “Osteoporosis Methods in Molecular Medicine” Westendorf JJ. (Ed), Humana Press. pp

125-134, 2008.

3. CHAPPARD D., BASLÉ M.F., LEGRAND E., AUDRAN M. Trabecular bone microarchitecture: a review. Morphologie 92, 162-170, 2008.

Page 21: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 21 -

4. DUBOIS S., ABRAHAM P., ROHMER V., RODIEN P., AUDRAN M., DUMAS J.F., RITZ P.

Thyroxine therapy in euthyroid patients does not affect body composition or muscular function. Thyroid. 18, 13-9, 2008.

5. DUMAS A., MOREAU M.F., GUILLET C., BASLE M.F., CHAPPARD D. Isolation of

osteoprogenitors from murine bone marrow by selection of CD11b negative cells.

Cytotechnology, 58, 163–171, 2008.

6. DUMAS A., MOREAU M.F., GUILLET C., BASLE M.F., CHAPPARD D. Isolation of

osteoprogenitors from murine bone marrow by selection of CD11b negative cells.

Cytotechnology, 58, 163–171, 2008.

7. FELLAH B.H,. GAUTHIER O., WEISS P., CHAPPARD D., LAYROLLE P. Osteogenicity of

biphasic calcium phosphate ceramics and bone autograft in a goat model. Biomaterials 29,

1177-88, 2008.

8. GAUDIN-AUDRAIN C., GALLOIS Y., GRIZON-PASCARETTI F., HUBERT L., MASSIN P.,

BASLÉ M.F., CHAPPARD D. Osteopontin is histochemically detected by the AgNOR acid-

silver staining. Histol. Histopathol., 23, 469-478, 2008.

9. GUGGENBUHL P., FILMON R., MABILLEAU G., M.F. BASLE., CHAPPARD D. Iron

inhibits hydroxyapatite crystal growth in vitro. Metabolism. 57, 903–910, 2008

10. GUGGENBUHL, P., CHAPPARD, D., GARREAU, M., BANSARD, J.-Y., CHALES, G.,

ROLLAND, Y. Reproducibility of CT-based bone texture parameters of cancellous calf bone samples: Influence of slice thickness. Eur. J. Radiol., 67, 514-520, 2008.

11. GUIDOIN R., PEIRANO M.A.M., BARONE H.D., DOUVILLE Y., ZHANG Z., GUZMAN R.,

BERTONI H., MERHI Y., MARINOV G.R., McGREGOR R., ZHANG H., CHAPPARD D.,

DIONNE G., DENG X. Transrenal Deployment of a Modular Stent Graft to Repair AAAs

with Short Necks: Experiments in Dogs. Artif. Cells, Blood Subst. Biotechnol., 36, 310–

339, 2008.

12. LE GUEHENNEC L, GOYENVALLE E, LOPEZ-HEREDIA MA, WEISS P, AMOURIQ Y,

LAYROLLE P. Histomorphometric analysis of the osseointegration of four different implant surfaces in the femoral epiphyses of rabbits Clin. Oral Impl. Res., 19, 1103-1110, 2008.

13. LEGRAND E, BOUVARD B, AUDRAN M; Hypercalciuria: what report? What treatment?

Métab. Hormon. Diab. Nutr., 12, 227-228, 2008.

14. LEVASSEUR R. Mechanisms of osteonecrosis, Joint Bone Spine 75, 639-42, 2008

15. LIBOUBAN H., BLOUIN S., MOREAU M.F., BASLE, M.F., AUDRAN M., CHAPPARD D.

Early preventive effects of risedronate in a rat model of osteopenia due to orchidectomy

and localized disuse. Micron, 39, 998-1007, 2008.

Page 22: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 22 -

16. LOPEZ-HEREDIA M. A., GOYENVALLE E., AGUADO E., PILET P., LEROUX C., DORGET M., WEISS P., LAYROLLE P. Bone growth in rapid prototyped porous titanium implants. J. Biomed. Mater. Res. - Part A 85, 664-673, 2008.

17. MABILLEAU G, AGUADO E, STANCU IC, CINCU C, BASLÉ MF, CHAPPARD D. Effects

of FGF2 release from a hydrogel polymer on bone mass and microarchitecture.

Biomaterials, 2008; 29:1593-1600.

18. MABILLEAU G., CINCU C., BASLE M.F., CHAPPARD D. Polymerization of 2-

(hydroxyethyl) methacrylate by two different initiator / accelerator systems: a Raman

spectroscopic monitoring. J. Raman Spectroscopy, 39, 767–771, 2008.

19. MASSIN P., BOYER P., PERNIN J., JEANROT C. Navigated revision knee arthroplasty

using a system designed for primary surgery. Computer Aided Surgery, 13, 1–9, 2008.

20. MINNE H., AUDRAN M., SIMOES M. E., OBERMAYER-PIETSCH B., SIGURETHSSON

G., MARIN F., DALSKY G. P., NICKELSEN T. Bone density after teriparatide in patients

with or without prior antiresorptive treatment: one-year results from the EUROFORS study.

Curr. Med. Res. Opin. 24, 3117-3128, 2008.

21. OBERMAYER-PIETSCH BM, MARIN F, MCCLOSKEY EV, HADJI P, FARRERONS J,

BOONEN S, AUDRAN M. BARKER C, ANASTASILAKIS AD, FRASER WD, NICKELSEN

T. Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J. Bone Miner.

Res. 23, 1591-1600, 2008.

22. ROUGE-MAILLART C, GAUDIN A, LERMITE E, ARNAUD JP, PENNEAU; Safety and

accuracy of surgical precedures: case law evolution. J. Chirurgie, 145, 437-441, 2008.

23. ZADEGAN, F., RAOULD, A., BIZOT, P., NIZARD, R., SEDEL, L. Osteonecrosis after

allogeneic bone marrow transplantation, Clin. Orthod. Rel. Res. 46, 287-293, 2008.

24. ZAHARIA C., ZECHERU T., MARCULESCU B., FILMON R., MABILLEAU G., CINCU C.,

STAIKOS G., CHAPPARD D. Chemical structure of methylmethacrylate-2-

[20,30,50triiodobenzoyl]oxoethyl methacrylate copolymer, radio-opacity, in vitro and in vivo biocompatibility. Acta Biomater. 4, 1762-1769, 2008.

- 2007-

1. BARON-MENGUY C., BOCQUET A., GUIHOT A.L., CHAPPARD D.

ANDRIANTSITOHAINA R, LOUFRANI L., HENRION D. Effects of red wine polyphenols on

post-ischemic neovascularization model in rats: low doses are pro-angiogenic, high doses

anti-angiogenic. FASEB J, 21, 3511-3521, 2007.

Page 23: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 23 -

2. BLOUIN S., GALLOIS Y., MOREAU M.F., BASLÉ M.F., CHAPPARD D. Disuse and

orchidectomy have additional effects on bone loss in the aged male rat. Osteoporosis Int.

18, 85-92, 2007.

3. CHAPPARD D. JOSSELIN N., ROUGÉ-MAILLARD C, LEGRAND E., BASLÉ M.F.,

AUDRAN M. Bone microarchitecture in males with corticosteroid induced osteoporosis.

Osteoporosis Int. 18, 487 - 494, 2007.

4. CHAPPARD D., JOSSELIN N., LEGRAND E., BASLÉ M.F., AUDRAN M.,

Histomorphometry in the evaluation of trabecular microarchitecture. In: “First meeting on

bone quality”, Abbaye des Vaux de Cernay, Osteoporosis Int.18, 862-864, 2007.

5. COLLET C., MICHOU L., AUDRAN M., CHASSEIGNEAUX S., HILLIQUIN P., BARDIN T.,

LEMAIRE I., CORNÉLIS F., LAUNAY J.M., ORCEL P., LAPLANCHE J.L. Paget's disease

of bone in the French population: Novel SQSTM1 mutations, functional analysis, and

genotypephenotype correlations. J. Bone Miner. Res., 22, 310-317, 2007.

6. LE GUEHENNEC L., GOYENVALLE E., AGUADO E., PILET P., SPAETHE R., DACULSI

G. Influence of calcium chloride and aprotinin in the in vivo biological performance of a

composite combining biphasic calcium phosphate granules and fibrin sealant. J. Mater. Sci.-

Mater. Med. 18, 1489-1495, 2007.

7. LE NIHOUANNEN D., GOYENVALLE E., AGUADO E., PILET P., BILBAN M., DACULSI G.,

LAYROLLE P. Hybrid composites of calcium phosphate granules, fibrin glue, and bone

marrow for skeletal repair. J. Biomed. Mater. Res. - Part A 81, 399-408, 2007.

8. LE NIHOUANNEN D., SAFFARZADEH A., AGUADO E., GOYENVALLE E., GAUTHIER O.,

MOREAU F., PILET P., SPAETHE R., DACULSI G., LAYROLLE P. Osteogenic properties

of calcium phosphate ceramics and fibrin glue based composites. J. Mater. Sci.-Mater. Med.

18, 225-235, 2007.

9. LEGRAND E, AUDRAN M, GUGGENBUHL P, LEVASSEUR R, CHALES G, BASLE M.F.,

CHAPPARD D. Trabecular bone microarchitecture is related to the number of risk factors and etiology in osteoporotic men. Microsc. Res. Tech., 70, 952-959, 2007.

10. LEGRAND E, BOUVARD B, AUDRAN M, FOURNIER D, VALAT JP. Disk herniation-

induced sciatica: medical or surgical treatment? Joint Bone Spine 2007, 6, 927-32.

11. LEGRAND E, BOUVARD B, AUDRAN M, FOURNIER D, VALAT JP. Sciatica from disk

herniation: Medical treatment or surgery? Joint Bone Spine, 74,530-35, 2007.

12. MOREAU M.F., GUILLET C., MASSIN P., CHEVALIER S., GASCAN H., BASLE M. F.,

CHAPPARD D. Comparative effects of five bisphosphonates on apoptosis of macrophage

cells in vitro. Biochem. Pharmacol. 73, 718-723, 2007.

Page 24: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 24 -

13. RITZ P, SALLÉ A, AUDRAN M, ROHMER V. Comparison of different methods to assess

body composition of weight loss in obese and diabetic patients. Diabetes Research and

Clinical Practice, 77:405-11, 2007.

14. ROUX C, PRIOL G, FECHTENBAUM J, CORTET B, LIU-LÉAGE S, AUDRAN M. A clinical

tool to determine the necessity of spine radiography in postmenopausal women with

osteoporosis presenting with back pain. Ann. Rheum. Dis. 66:81-85, 2007.

15. RUSEN E., ZAHARIA C., ZECHERU, T., MARCULESCU B., FILMON R., CHAPPARD D.,

BADULESCU R., CINCU C. Synthesis and characterisation of core–shell structures for

orthopaedic surgery. J. Biomech. 40, 3349-3353, 2007.

16. SCHMIDT A., BLANCHET O., DIB M., BASLÉ M.F., IFRAH N., CHAPPARD D. Bone

changes in myelofibrosis with myeloid metaplasia: a histomorphometic and microcomputed tomographic study. Europ. J. Haematol. 78, 500-509, 2007.

17. SELLAM J, BOUVARD B, MASSON C, ROUSIERE M, VILLOUTREIX C, LACOMBE K,

KHANINE V, CHENNEBAULT JM, LECLECH C, AUDRAN M, BERENBAUM F. Use of

infliximab to treat psoriatic arthritis in HIV-positive patients. Joint Bone Spine 74,197-200,

2007.

18. STANCU I.C., LAYROLLE P, LIBOUBAN H., FILMON R., LEGEAY G., CINCU C., BASLE

M.F., CHAPPARD D. Preparation of macroporous poly (2-hydroxyethyl) methacrylate with interconnected porosity. J. Optoelectr. Adv. Mater. 9, 2125-2129, 2007.

19. ZAHARIA C., RUZEN E., MARCULESCU B., FILMON R., GAVAN M., CONSTANTIN N.,

CHAPPARD D., ZECHERU T., CINCU C. New acrylic radio-opaque cement. J. Optoelectr.

Adv. Mater. 9, 2143-2146, 2007.

- 2006-

1. AUDRAN M. Drug combination strategies for osteoporosis. Joint Bone Spine 73, 374-378,

2006.

2. BLOUIN S., GALLOIS Y., MOREAU M.F., BASLÉ M.F., CHAPPARD D. Disuse and orchidectomy have additional effects on bone loss in the aged male rat. Osteoporosis Int.18,

85-92, 2007.

3. BLOUIN S., MOREAU M.F., BASLÉ M.F., CHAPPARD D. Relations between microCT

measurements and texture analysis in two rat models of bone metastases. Cell Tissues

Organs. 182, 182-192, 2006.

4. BLOUIN S., MOREAU M.F., WEISS P., DACULSI G., CHAPPARD D. Evaluation of an

injectable bone substitute ( TCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in

severely osteopenic and aged rats J. Biomed. Mater. Res. 78, 570-580, 2006.

Page 25: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 25 -

5. CHAPPARD D. GRIZON-PASCARETTI F., GALLOIS Y., MERCIER P., BASLÉ M.F.,

AUDRAN,

M. Medullar fat influences texture analysis of trabecular microarchitecture of X-ray radiographs.

Europ. J. Radiol. 58, 404-410, 2006.

6. CHAPPARD, D. Structural properties: Cortical microarchitecture. Chapître de livre in: "The

Bone Quality Book", Dempster D., Felsenberg D., Van der Geest S. Ed. Excerpta Medica,

ISBN 90219888321, pp 35-41, 2006.

7. DUMAS A., GAUDIN-AUDRAIN C., MABILLEAU G., MASSIN P., HUBERT L., BASLÉ M.

F., CHAPPARD D. Processes used to purify human bone allografts alter matrix surface and

cytocompatibility. Biomaterials, 27, 4204-4211, 2006.

8. GOYENVALLE E., AGUADO E., NGUYEN J. M., PASSUTI N., LE GUEHENNEC L.,

LAYROLLE P., DACULSI G. Osteointegration of femoral stem prostheses with a bilayered

calcium phosphate coating. Biomaterials 27, 1119-1128, 2006.

9. GUGGENBUHL P., BODIC F., HAMEL L., BASLÉ M.F., CHAPPARD D. Texture analysis of

Xray radiographs is correlated with bone micro-computed tomography. Osteoporosis Int. 17,

447 - 454, 2006

10. GUIDOIN R, ZHANG Z, DOUVILLE Y, BONNY JM, RENOU JP, BASLE MF, ZARINS CK,

LEGRAND AP, GUZMAN R. MRI virtual biopsies : analysis of an explanted endovascular

device and perspectives for the future. Artificial Cells, Blood Substitutes, Biotechnol. 34,

241-261, 2006.

11. GUILLAUME B, LACOSTE J.P., GABORIT N., BROSSARD G., CRUARD A., BASLÉ M.F.,

CHAPPARD D. Microcomputed tomography used in the analysis of the morphology of root

canals in extracted wisdom teeth Brit. J. Oral Maxillofac. Surg. 44, 240-244, 2006. : 0.573

12. LEGRAND E., BOUVARD B, LEVASSEUR R., CHAPPARD D., AUDRAN M. La

densitométrie osseuse. Traduction anglaise : Bone densitometry. Rev. Rhum. 73, 795–803,

2006.

13. LEGRAND E., MASSIN P., LEVASSEUR R., HOPPE E., CHAPPARD D., AUDRAN M.

Stratégie diagnostique et principes thérapeutiques au cours des spondylodiscites

infectieuses bactériennes.). Rev. Rhum., 73, 373-379, 2006. Traduction anglaise :

Management and treatment of non tuberculous spondylodiscitis Joint Bone Spine. 2006.

14. LIBOUBAN H., ONNO C., GRIZON F., MOREAU M.F., BASLÉ M.F., CHAPPARD D.

Absence of renal lesions in C57BL/KaLwRij mice with advanced myeloma due to 5T2MM

cells. Leukaemia es. 30, 1371–1375, 2006. :

15. MABILLEAU G., BASLÉ M.F., CHAPPARD D. Evaluation of surface roughness of hydrogels by fractal texture analysis during swelling. Langmuir, 22, 4843 - 4845, 2006.

Page 26: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 26 -

16. MABILLEAU G., BOURDON B., JOLY-GUILLOU M. L., FILMON R., BASLÉ M.F.,

CHAPPARD D. Influence of fluoride, hydrogen peroxide and lactic acid on the corrosion resistance of commercially pure titanium. Acta Biomater. 2, 121-129, 2006.

17. MABILLEAU G., STANCU I. C., HONORÉ T., LEGEAY G., CINCU C., BASLÉ M.F.,

CHAPPARD D. Effects of the chain length of cross-linkers on poly(2-hydroxyethyl methacrylate)

(pHEMA) swelling and biomechanical properties J. Biomed. Mater. Res A., 77: 35-42, 2006.

18. MASSIN P., LEGRAND E., CRONIER P., CHAPPARD D., AUDRAN M. Diagnosis and

treatment of adult pyogenic chronic osteomyelitis. Joint Bone Spine. 73, 3 80-386, 2006.

- 2005-

1. BLOUIN S., BASLÉ M.F., CHAPPARD D. Rat models of bone metastases. Clin. Exp.

Metastasis. 22, 605-614, 2005.

2. BODIC F., HAMEL L., LEROUXEL E., BASLÉ M.F., CHAPPARD D. Perte osseuse et dents.

Rev. Rhum. 72, 397-403, 2005. Traduction anglaise : Bone loss and teeth. Joint Bone Spine,

72, 215-221, 2005.

3. CHAPPARD D., GUGGENBUHL P., LEGRAND E., BASLÉ M.F., AUDRAN M. Texture analysis

of X-ray radiographs is correlated with bone histomorphometry. J. Bone Miner. Metab. 23, 24-

29, 2005.

4. CHAPPARD D., RETAILLEAU-GABORIT N., LEGRAND E., BASLÉ M.F., AUDRAN M. Comparison insight bone measurements by histomorphometry and µCT. J. Bone Miner Res.,

20, 1177-1184, 2005

5. GAUTHIER O., MULLER R., VON STECHOW D., LAMY B., WEISS P., BOULER J. M.,

AGUADO E., DACULSI G. In vivo bone regeneration with injectable calcium phosphate

biomaterial: a three-dimensional micro-computed tomographic, biomechanical and SEM study.

Biomaterials 26, 5444-5453, 2005.

6. JEGOUX F., GOYENVALLE E., BAGOT D'ARC M., AGUADO E., DACULSI G. In vivo

biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant. Arch. Orthop. Trauma Surg. 125, 153-159, 2005.

7. LEVASSEUR R., LEGRAND E., CHAPPARD D., AUDRAN M. Contrôle central de la masse

osseuse : Implications thérapeutiques potentielles. Central control of bone mass: potential

therapeutic implications. Joint Bone Spine. 72, 474-476, 2005.

8. MALARD O., GUICHEUX J., BOULER J. M., GAUTHIER O., DE MONTREUIL C. B., AGUADO

E., PILET P., LEGEROS R., DACULSI G. Calcium phosphate scaffold and bone marrow for

bone reconstruction in irradiated area: a dog study. Bone 36, 323-330, 2005.

Page 27: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 27 -

9. ROUX C., GARNERO P., THOMAS T., SABATIER J. P., ORCEL P., AUDRAN M.

Recommendations for monitoring antiresorptive therapies in postmenopausal osteoporosis. Joint Bone Spine 72, 26-31, 2005.

- 2004-

1. AUDRAN M. Benefits, limitations, and impact of osteoporosis risk factor identification. Joint

Bone Spine 71, 361-362, 2004.

2. BEHETS C., WILLIAMS J.M., CHAPPARD D., DEVOGELAER J.P., MANICOURT D.H. Effects

of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions

after acute anterior cruciate ligament deficiency. J Bone Miner Res. 19, 1821-1826, 2004.

3. BOUTRY N, CORTET B, CHAPPARD D, DUBOIS P, DEMONDION X, MARCHANDISE X,

COTTEN A. Bone structure of the calcaneus: analysis with magnetic resonance imaging and

correlation with histomorphometric study. Osteoporos Int. 15, 827-833, 2004.

4. CHAPPARD D., INSALACO P., AUDRAN M. Aluminium osteodystrophy and celiac disease.

Calcif. Tissue Int. 74, 212-213, 2004.

5. CHAPPARD D., MOQUEREAU M., MERCIER P., GALLOIS Y., LEGRAND E., AUDRAN M.,

BASLÉ M.F. Ex-vivo bone mineral density of the wrist: influence of medullar fat. Bone, 34,

1023-1028, 2004.

6. CORTET B, CHAPPARD D, BOUTRY N, DUBOIS P, COTTEN A, MARCHANDISE X.

Relationship between computed tomographic image analysis and histomorphometry for

microarchitectural characterization of human calcaneus. Calcif Tissue Int. 75, 23-31, 2004.

7. GUIDOIN R, DOUVILLE Y, BASLE MF, KING M, MARINOV GR, TRAORE A, ZHANG Z,

GUILLEMOT F, DIONNE G, SUMANASINGHE R, LEGRAND AP, GUIDOIN MF,

PORTEDURRIEU MC, BAQUEY C. Biocompatibility studies of the Anaconda stent-graft and

observations of nitinol corrosion resistance. J. Endovasc. Ther. 11, 385-403, 2004.

8. GUIDOIN RG, LANGEVIN F, BASLE MF, ALARCONE C, GRIZON F, LEGRAND AP,

BASSECATHALINAT B, FRANCONI JM, BAQUEY C. Can magnetic resonance imaging be

the key technique to visualize and investigate endovascular biomaterials? Artif Cells Blood

Substit. Immobil. Biotechnol. 32, 105-127, 2004.

9. HURE G., AGUADO E., GRIZON F., BASLÉ M.F., CHAPPARD D. Some biomechanical and

histological characteristics of early loaded locking pin and expandable implants. A pilot

histological study in the dog. Clin. Impl. Dent. Rel. Res. 6, 33-39, 2004.

10. LEROUXEL E., LIBOUBAN H., MOREAU M.F., BASLÉ M.F., AUDRAN M., CHAPPARD D.

Mandibular bone loss in an animal model of male osteoporosis (the orchidectomized rat): a radiographic and densitometric study. Osteoporosis Int. 15, 814-819, 2004.

Page 28: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 28 -

11. LIBOUBAN H., MOREAU M.F., BASLÉ M.F., BATAILLE R., CHAPPARD D. Selection of an

highly agressive myeloma cell line by an altered bone microenvironment in the C57BL/KaLwRij mouse” Biochem Biophys. Res. Commun. 316, 859-866, 2004.

12. MABILLEAU G., MOREAU M.F., FILMON R., BASLÉ M.F., CHAPPARD D. Biodegradability of

poly (2-hydroxyethyl methacrylate) in the presence of the J774.2 macrophagic cell line.

Biomaterials, 25, 5155-5162, 2004.

13. MASSIN P., CHAPPARD D., FLAUTRE B., HARDOUIN P. Migration of polyethylene particles

around non-loosened cemented femoral components from a total hip arthroplasty. An autopsy

study. J Biomed. Mater. Res. 69B, 205-215, 2004.

14. MASSIN P., VIGUIER E., FLAUTRE B., HARDOUIN P., ASTOIN E., DUPONCHEL B.

Migration of polyethylene debris along well-fixed cemented implants. J Biomed. Mater. Res.

68B, 140-148, 2004.

15. REGINSTER J. Y., BEN SEDRINE W., VIETHEL P., MICHELETTI M. C., CHEVALLIER T.,

AUDRAN M. Validation of OSIRIS, a prescreening tool for the identification of women with an

increased risk of osteoporosis. Gynecol Endocrinol 18, 3-8, 2004.

16. RINGUIER B., LEBOUCHER B., LEBLANC M., TROUSSIER F., DUVEAU E., AUDRAN M.,

GINIES J. L. Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral

density. Arch Pediatr 11, 1445-1449, 2004.

17. STANCU I.C., FILMON R., CINCU C., MARCULESCU B., ZAHARIA C., TOURMEN Y., BASLÉ M.F., CHAPPARD D. Synthesis of methacryloyloxyethyl phosphate copolymers and in vitro

calcification capacity. Biomaterials. 25, 205-213, 2004.

18. STANCU I.C., FILMON R., GRIZON F., ZAHARIA C., CINCU C., BASLÉ M.F., CHAPPARD D.

The in vivo calcification capacity of a copolymer, based on methacryloyloxyethyl phosphate,

does not favor osteoconduction. J Biomed. Mater. Res. 69A, 584-592, 2004.

- 2003-

1. ATMANI H, CHAPPARD D, BASLE M.F. Proliferation and differentiation of osteoblasts and

adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J.

Cellular Biochem. 89, 364-372, 2003.

2. AUDRAN M., INSALACO P. Parathyroid hormone therapy for osteoporosis. Joint Bone Spine

70, 315-317, 2003.

3. CHAPPARD D., DEGASNE I., LESOURD M., HURÉ G., LEGRAND E., AUDRAN M., BASLÉ

M.F. Image analysis Measurements of roughness by texture and fractal analysis correlates

with contact profilometry. Biomaterials. 24, 1399-1407, 2003.

Page 29: 2020 - - 2019 · Maxillary sinus floor elevation using Beta-Tricalcium-Phosphate (beta-TCP) or natural bone: ... GLP-1 Receptor agonist exenatide ameliorates bone composition and

Equipe GEROM "Remodelage Osseux et bioMatériaux" Directeur: Pr . D. CHAPPARD

- 29 -

4. LIBOUBAN H., MOREAU M.F., BASLÉ M.F., BATAILLE R., CHAPPARD D. Increased bone

remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone. 33, 283-292, 2003.

5. MICHALAK S., ROUSSELET M.C., BEDOSSA P., PILETTE C., CHAPPARD D., OBERTI F.,

GALLOIS Y., CALÈS P. Respective role of porto-septal fibrosis and centrolobular fibrosis in

alcoholic liver diseases. J. Pathol. 201, 55-62, 2003.

6. WEISS P., OBADIA L., MAGNE D., BOURGES X, RAU C., WEITKAMP T., KHAIROUN I.,

BOULER J.M., CHAPPARD D., GAUTHIER O., DACULSI G. Synchrotron X-ray

microtomography (on a micron scale) provides three-dimensional imaging representation of

bone ingrowth in calcium phosphate biomaterials. Biomaterials. 24, 4591-4601, 2003.


Recommended